An effective treatment in Erdheim Chester disease: vemurafenib: a case report
ConclusionsBRAF V600E mutation is frequently seen in ECD. Vemurafenib plays an active role in targeted therapy.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: General Medicine | Histiocytosis | Laboratory Medicine | Langerhans Cell Histiocytosis (LCH) | Pain | Rare Diseases | Women